SCICON MR 30mg Tablet by Scilife Pharma is a high-quality Gliclazide modified-release (MR) tablet designed to provide sustained blood sugar control for adults with Type 2 Diabetes Mellitus. The 30mg MR formulation ensures gradual and steady release of Gliclazide, helping manage fasting and post-meal glucose levels effectively while reducing the risk of hypoglycemia.
This tablet is suitable for patients who require long-acting, once-daily blood sugar control to maintain stable glucose levels throughout the day.
Gliclazide MR stimulates insulin secretion from the pancreas, helping regulate fasting and postprandial glucose levels.
Maintains healthy beta-cell function, enabling better response to glucose levels.
Unlike some diabetes medications, Gliclazide MR is generally weight-neutral when combined with diet and exercise.
May help reduce the risk of diabetes-related vascular complications over long-term use.
Simplifies diabetes management, improving adherence and convenience for patients.
SCICON MR 30mg Tablet is recommended for:
Not recommended for:
Common side effects:
Important: Keep glucose tablets or sugary snacks nearby in case of hypoglycemia. Seek medical attention for severe symptoms.
⭐⭐⭐⭐⭐ “SCICON MR 30mg helps me manage my sugar throughout the day. Easy to take once daily and effective.” – Ayesha, Karachi
⭐⭐⭐⭐⭐ “Good long-acting diabetes medicine. My blood sugar is more stable than before.” – Fahad, Lahore
